MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/08897077.2021.1986768

Медицинская библиотека · Substance abuse · 2021

COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.

Levander Ximena A, Pytell Jarratt D, Stoller Kenneth B, Korthuis P Todd, Chander Geetanjali

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Background

In the United States, methadone for treatment of opioid use disorder is dispensed via highly-regulated accredited opioid treatment programs (OTP). During the COVID-19 pandemic, federal regulations were loosened, allowing for greater use of take-home methadone doses. We sought to understand how OTP leaders responded to these policy changes.

Methods

We distributed a multistate electronic survey from September to November 2020 of OTP leadership to members of the American Association for the Treatment of Opioid Dependence (AATOD) who self-identified as leaders of OTPs. We asked study participants about how their OTP(s) implemented COVID-19-related policy changes into their clinical practice focusing on provision of take-home methadone doses, factors used to determine patient stability, and potential concerns about increased take-home doses. We used Chi-square test to compare survey responses between characterizations of the OTPs.

Results

Of 170 survey respondents (17% response rate), the majority represented leadership of for-profit OTPs (69%) and were in a Southern state (54%). Routine allowances and practices related to take-home methadone doses varied across OTPs during the COVID-19 pandemic: 80 (47%) reported 14 days for newly enrolled patients (within past 90 days), 89 (52%) reported 14 days for "less stable" patients, and 112 (66%) reported 28 days for "stable" patients.

Conclusions

We found that not all eligible OTP leaders adopted the practice of routinely allowing newly enrolled, "less stable," and "stable" patients on methadone to have increased take-home doses up to the limit allowed by federal regulations during COVID-19. The pandemic provides an opportunity to critically re-evaluate long-established methadone and OTP regulations in preparation for future emergencies.

Для цитирования: Levander Ximena A, Pytell Jarratt D, Stoller Kenneth B, Korthuis P Todd, Chander Geetanjali. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.. Substance abuse. 2021. DOI: 10.1080/08897077.2021.1986768.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.